Conbercept can bind to PlGF, and a previous study reported that retinal PlGF levels were decreased significantly in the conbercept (KH902)-treated group in an oxygen-induced retinopathy model.30 However, the serum level of PlGF was not suppressed in this study. This evidence concerns the gene PGF and retinal disorder.